Similar Search Results

What factors determine the choice of public engagement undertaken by health technology assessment decision-making organization

Wortley, Sally; Street, Jackie; Lipworth, Wendy; … - In: Journal of health organization and management 30 (2016) 6, pp. 872-890

Persistent link: https://www.econbiz.de/10011610017

The ethical domain in Health Technology Assessment (HTA) : basics, approaches and issues

Sacchini, Dario; Refolo, Pietro; Minacori, Roberta; … - In: Rivista internazionale di scienze sociali 124 (2016) 3/4, pp. 385-396

Persistent link: https://www.econbiz.de/10011659123

A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe

Lee, Dawn C.; Gladwell, Daniel; Hatswell, Anthony J.; … - In: Health economics review 4 (2014) 6, pp. 1-15

In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-therapy with chronic anti-epileptic treatment, a rescue medication is required. In...

Persistent link: https://www.econbiz.de/10010528456

Advanced therapy medicinal products : value judgement and ethical evaluation in health technology assessment

Gonçalves, Elisabete - In: The European journal of health economics : HEPAC ; … 21 (2020) 3, pp. 311-320

Persistent link: https://www.econbiz.de/10012221980

Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare

Jönsson, Bengt; Hampson, Grace; Michaels, Jonathan; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 3, pp. 427-438

Persistent link: https://www.econbiz.de/10012005044

Analytic hierarchy process as a tool for group evaluation of healthcare equipment

Peregrin, Stanislav; Jablonsky, Josef - In: International journal of business and systems research 10 (2016) 2/3/4, pp. 124-141

Persistent link: https://www.econbiz.de/10011675238

Pricing implications of non-marginal budgetary impacts in health technology assessment : a conceptual model

Howdon, Daniel; Lomas, James - 2017

Persistent link: https://www.econbiz.de/10011751722

Costly sequential experimentation and project valuation with an application to health technology assessment

Thijssen, Jacco J. J.; Bregantini, Daniele - In: Journal of economic dynamics & control 77 (2017), pp. 202-229

Persistent link: https://www.econbiz.de/10011817466

Four years of early benefit assessment of new drugs in Germany : a qualitative study on methodological requirements for quality of life data

Blome, Christine; Augustin, Matthias; Metin, Hidayet; … - In: The European journal of health economics : HEPAC ; … 18 (2017) 2, pp. 181-193

Persistent link: https://www.econbiz.de/10011867761

Why do health technology assessment coverage recommendations for the same drugs differ across settings? : applying a mixed methods framework to systematically compare orphan drug d...

Nicod, Elena - In: The European journal of health economics : HEPAC ; … 18 (2017) 6, pp. 715-730

Persistent link: https://www.econbiz.de/10011868947